The Soterix Medical 1×1-LTE is the only tDCS device optimized for susceptible populations with features optimized to reduce anxiety and sensation including SmartScan™, Relax™, and Tickle™. Additionally with an exclusive feature of Soterix Medical LTE™, makes it the most intelligent power and transient management system for currents up to 1.5 mA.
Limited Total Energy™ (LTE)
Limited Total Energy for tDCS (LTE-tDCS) was developed exclusively by Soterix engineers. LTE limits the voltage and power required for tDCS through the use of adaptive ramp-up stimulation and intelligent energy management for currents up to 1.5 mA. The Soterix Medical 1×1 tDCS-LTE includes the most advanced transient protection in the industry, an electrode becoming temporarily disconnected, for example due to subject movement. In addition, should resistance increase to atypical levels, LTE-tDCS will automatically reduce the applied current so as to maintain a low voltage.
Soterix Medical tDCS-LTE is a unique system that provides an additional safety margin, without compromising efficacy, when stimulating susceptible subjects.
- Pediatric stroke and transcranial direct current stimulation: methods for rational individualized dose optimization. Frontiers in Human Neuroscience Gillick et al. (2014)
- Safety and Feasibility of Transcranial Direct Current Stimulation in Pediatric Hemiparesis: Randomized Controlled Preliminary Study. Physical Therapy. Gillick et al. (2015)
Proven to Limit Power During tDCS
The difference between conventional tDCS and tDCS-LTE is that conventional tDCS applies a fixed ramp slope while tDCS-LTE varies ramp intensity to limit power delivery. Soterix tDCS-LTE also limits power transients that might occur during tDCS due to sudden changes in resistance. tDCS-LTE further enhances abort-protection features already enabled on all Soterix 1×1 devices. Finally, tDCS-LTE alerts the operator when a high-power condition occurs and automatically activates LTE to reduce power consumption.
Dose Guidelines for Susceptible Subjects
In tDCS one size does not fit all, and nowhere is this more sensitive than in susceptible populations. Soterix Medical scientists are working with leading pediatric neurology clinical research centers to refine and optimize dose strategies. With access to Soterix Medical Solution services and Software, tDCS 1×1-LTE users are part of this community and dialogue.
- Pediatric stroke and transcranial direct current stimulation: methods for rational individualized dose optimization. Frontiers in Human Neuroscience Gillick et al. (2014)
- Dosage considerations for transcranial direct current stimulation in children: a computational modeling study. PLOSE ONE 2013 Kessler et al.
Learn more about Soterix Medical 1×1 LTE tDCS device, please click https://soterixmedical.com/research/1×1/tdcs/lte or reach us here.